{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:22:53Z","timestamp":1793362973500,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006668","name":"FonCyT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010442","name":"Universidad Nacional de C\u00f3rdoba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010442","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ijpharm.2023.123720","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T11:16:40Z","timestamp":1702725400000},"page":"123720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Significant progress in improving Atorvastatin dissolution rate: Physicochemical characterization and stability assessment of self-dispersible Atorvastatin\/Tween 80\u00ae nanocrystals formulated through wet milling and freeze-drying"],"prefix":"10.1016","volume":"650","author":[{"given":"Alan","family":"Rossetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Andr\u00e9s","family":"Real","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Andr\u00e9s","family":"Barrientos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Alberto","family":"Allemandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0414-8972","authenticated-orcid":false,"given":"Alejandro J.","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Real","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago Daniel","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2023.123720_b0005","article-title":"Lipid-lowering efficacy of atorvastatin","volume":"2015","author":"Adams","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijpharm.2023.123720_b0010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijpharm.2016.03.045","article-title":"PD-PK evaluation of freeze-dried atorvastatin calcium-loaded poly-\u03b5-caprolactone nanoparticles","volume":"504","author":"Ahmed","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2023.123720_b0015","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1039\/D1NA00438G","article-title":"Anionic\/nonionic surfactants for controlled synthesis of highly concentrated sub-50 nm polystyrene spheres","volume":"3","author":"Al Najjar","year":"2021","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.ijpharm.2023.123720_b0020","doi-asserted-by":"crossref","unstructured":"Alloubani, A., Nimer, R., Samara, R., 2021. Relationship between hyperlipidemia, cardiovascular disease and stroke: a systematic review. Curr. Cardiol. Rev. 17, 051121189015. doi: 10.2174\/1573403X16999201210200342.","DOI":"10.2174\/1573403X16999201210200342"},{"key":"10.1016\/j.ijpharm.2023.123720_b0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1208\/s12248-011-9272-y","article-title":"Dissolution testing for generic drugs: an FDA perspective","volume":"13","author":"Anand","year":"2011","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpharm.2023.123720_b0030","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejps.2011.08.001","article-title":"Enhanced bioavailability of nano-sized chitosan-atorvastatin conjugate after oral administration to rats","volume":"44","author":"Anwar","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2023.123720_b0035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijpharm.2012.09.040","article-title":"A combined microhydrodynamics-polymer adsorption analysis for elucidation of the roles of stabilizers in wet stirred media milling","volume":"439","author":"Bilgili","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2023.123720_b0040","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1023\/B:JMSC.0000039193.69784.1d","article-title":"Mechanochemical modification and synthesis of drugs","volume":"39","author":"Boldyrev","year":"2004","journal-title":"J. Mater. Sci."},{"key":"10.1016\/j.ijpharm.2023.123720_b0045","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1590\/S0100-40422007000200033","article-title":"Estatinas hipolip\u00eamicas e novas tend\u00eancias terap\u00eauticas","volume":"30","author":"Campo","year":"2007","journal-title":"Quim Nova"},{"key":"10.1016\/j.ijpharm.2023.123720_b0050","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1208\/s12248-017-0064-x","article-title":"Development considerations for nanocrystal drug products","volume":"19","author":"Chen","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpharm.2023.123720_b0055","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/10717540802039113","article-title":"Effect of polymer molecular weight on nanocomminution of poorly soluble drug","volume":"15","author":"Choi","year":"2008","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2023.123720_b0060","doi-asserted-by":"crossref","unstructured":"Cort\u00e9s, H., Hern\u00e1ndez-Parra, H., Bernal-Ch\u00e1vez, S.A., Del Prado-Audelo, M.L., Caballero-Flor\u00e1n, I.H., Borbolla-Jim\u00e9nez, F. V., Gonz\u00e1lez-Torres, M., Maga\u00f1a, J.J., Leyva-G\u00f3mez, G., 2021. Non-ionic surfactants for stabilization of polymeric nanoparticles for biomedical uses. Mater. 14, 3197. doi: 10.3390\/MA14123197.","DOI":"10.3390\/ma14123197"},{"key":"10.1016\/j.ijpharm.2023.123720_b0065","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jconrel.2006.11.011","article-title":"Turbidimetric measurement and prediction of dissolution rates of poorly soluble drug nanocrystals","volume":"117","author":"Crisp","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2023.123720_b0070","unstructured":"Evoluci\u00f3n de las dispensas de tratamientos para el colesterol y triglic\u00e9ridos en los primeros 8 meses de 2022-2023 \u2013 Observatorio SMS \u2013 COFA [WWW Document], n.d. URL http:\/\/observatorio.cofa.org.ar\/index.php\/2023\/10\/06\/evolucion-de-las-dispensas-de-tratamientos-para-el-colesterol-y-trigliceridos-en-los-primeros-8-meses-de-2022-2023\/(accessed 11.27.23)."},{"key":"10.1016\/j.ijpharm.2023.123720_b0075","article-title":"On a highway to the brain: a review on nose-to-brain drug delivery using nanoparticles","volume":"29","author":"Formica","year":"2022","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.ijpharm.2023.123720_b0080","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1021\/acs.cgd.1c01442","article-title":"Intelligent mechanochemical design of co-amorphous mixtures","volume":"22","author":"Gr\u00f6ls","year":"2022","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ijpharm.2023.123720_b0085","unstructured":"International conference on harmonization (ICH): new developments in quality [WWW Document], n.d. URL https:\/\/apps.who.int\/iris\/handle\/10665\/73983?locale-attribute=es& (accessed 7.31.23)."},{"key":"10.1016\/j.ijpharm.2023.123720_b0090","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.powtec.2015.08.047","article-title":"Pharmacological and histological examination of atorvastatin-PVP K30 solid dispersions","volume":"286","author":"Jahangiri","year":"2015","journal-title":"Powder Technol."},{"key":"10.1016\/j.ijpharm.2023.123720_b0095","article-title":"Freeze-drying of drug nanosuspension\u2013 study of formulation and processing factors for the optimization and characterization of redispersible cilostazol nanocrystals","volume":"74","author":"Jakubowska","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2023.123720_b0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jconrel.2005.11.013","article-title":"Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs","volume":"111","author":"Jinno","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2023.123720_bib316","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1208\/s12248-008-9061-4","article-title":"Understanding the effect of API properties on bioavailability through absorption modeling","volume":"10","author":"Kesisoglou","year":"2008","journal-title":"AAPS J"},{"key":"10.1016\/j.ijpharm.2023.123720_b0105","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1208\/s12249-011-9673-3","article-title":"Enhanced bioavailability of atorvastatin calcium from stabilized gastric resident formulation","volume":"12","author":"Khan","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2023.123720_b0110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3797\/scipharm.1104-26","article-title":"Enhanced bioavailability and dissolution of atorvastatin calcium from floating microcapsules using minimum additives","volume":"80","author":"Khan","year":"2012","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.ijpharm.2023.123720_b0115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijpharm.2008.04.006","article-title":"Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process","volume":"359","author":"Kim","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2023.123720_b0120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijbiomac.2013.03.068","article-title":"Oral absorption of atorvastatin solid dispersion based on cellulose or pyrrolidone derivative polymers","volume":"59","author":"Kim","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijpharm.2023.123720_b0125","doi-asserted-by":"crossref","first-page":"16520","DOI":"10.1039\/C5RA26674B","article-title":"Atorvastatin calcium loaded PCL nanoparticles: development, optimization, in vitro and in vivo assessments","volume":"6","author":"Kumar","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijpharm.2023.123720_b0130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2147\/IJN.S77731","article-title":"Chitosan based atorvastatin nanocrystals: effect of cationic charge on particle size, formulation stability, and in-vivo efficacy","volume":"10","author":"Kurakula","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2023.123720_b0135","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2337\/dc16-1958","article-title":"Triglyceride and HDL-C dyslipidemia and risks of coronary heart disease and ischemic stroke by glycemic dysregulation status: the strong heart study","volume":"40","author":"Lee","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijpharm.2023.123720_b0140","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijpharm.2007.12.032","article-title":"Characteristics of polymers enabling nano-comminution of water-insoluble drugs","volume":"355","author":"Lee","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2023.123720_b0145","doi-asserted-by":"crossref","unstructured":"Lin, M., Fu, Z.Y., Tan, H.R., Tan, J.P.Y., Ng, S.C., Teo, E., 2012. Hydrothermal synthesis of CeO2 nanocrystals: Ostwald ripening or oriented attachment? Cryst. Growth Des. 12, 3296\u20133303. doi: 10.1021\/CG300421X\/SUPPL_FILE\/CG300421X_SI_001.PDF.","DOI":"10.1021\/cg300421x"},{"key":"10.1016\/j.ijpharm.2023.123720_bib317","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1208\/s12248-008-9050-7","article-title":"Evaluation of nanosuspensions for absorption enhancement of poorly soluble drugs: In vitro transport studies across intestinal epithelial monolayers","volume":"10","author":"Lenhardt","year":"2008","journal-title":"AAPS J"},{"key":"10.1016\/j.ijpharm.2023.123720_bib318","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijpharm.2011.01.059","article-title":"Preparation and in vitro\/in vivo evaluation of revaprazan hydrochloride nanosuspension","volume":"408","author":"Li","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2023.123720_b0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0939-6411(00)00091-6","article-title":"Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards","volume":"50","author":"L\u00f6benberg","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2023.123720_b0155","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ajps.2014.12.006","article-title":"Overview of milling techniques for improving the solubility of poorly water-soluble drugs","volume":"10","author":"Loh","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2023.123720_b0160","article-title":"Formulation and evaluation of nanocrystals of a lipid lowering agent","author":"Louis","year":"2016","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.ijpharm.2023.123720_b0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijpharm.2014.02.004","article-title":"Understanding the relationship between wettability and dissolution of solid dispersion","volume":"465","author":"Lu","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2023.123720_b0170","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1080\/03639045.2018.1508225","article-title":"Investigation of different types of nano drug delivery systems of atorvastatin for the treatment of hyperlipidemia","volume":"44","author":"Mathur","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2023.123720_b0175","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jconrel.2022.03.012","article-title":"Nanocrystals as a master key to deliver hydrophobic drugs via multiple administration routes","volume":"345","author":"McGuckin","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2023.123720_b0180","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-020-01777-y","article-title":"Nanocrystals of novel valerolactam-fenbendazole hybrid with improved in vitro dissolution performance","volume":"21","author":"Melian","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2023.123720_b0185","article-title":"Atorvastatin-loaded spray-dried PLGA microparticles for local prevention of intimal hyperplasia: drug release rate optimization and activity on synthetic vascular smooth muscle cells","volume":"79","author":"Melnik","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2023.123720_b0190","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1023\/A:1016051316815","article-title":"Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs","volume":"13","author":"Merisko-Liversidge","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2023.123720_bib319","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijpharm.2012.09.034","article-title":"Drug nanocrystals in the commercial pharmaceutical development process","volume":"453","author":"M\u00f6schwitzer","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2023.123720_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2011.01.007","article-title":"State of the art of nanocrystals \u2013 special features, production, nanotoxicology aspects and intracellular delivery","volume":"78","author":"M\u00fcller","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2023.123720_b0200","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/IJN.S595","article-title":"Nanocrystal technology, drug delivery and clinical applications","volume":"3","author":"M\u00fcller Junghanns","year":"2008","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2023.123720_b0205","first-page":"303","article-title":"DYSLIPIDEMIAS","author":"Murphy","year":"2009","journal-title":"Pharmacol. Ther. Princ. Pract."},{"key":"10.1016\/j.ijpharm.2023.123720_b0210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jddst.2015.11.003","article-title":"Atorvastatin\u2013cyclodextrin systems: physiochemical and biopharmaceutical evaluation","volume":"31","author":"Palanisamy","year":"2016","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2023.123720_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119501","article-title":"Ricobendazole nanocrystals obtained by media milling and spray drying: pharmacokinetic comparison with the micronized form of the drug","volume":"585","author":"Paredes","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2023.123720_b0220","doi-asserted-by":"crossref","unstructured":"Paredes, Alejandro J., Camacho, N.M., Schofs, L., Dib, A., Zarazaga, M. del P., Litterio, N., Allemandi, D.A., S\u00e1nchez Bruni, S., Lanusse, C., Palma, S.D., 2020b. Ricobendazole nanocrystals obtained by media milling and spray drying: Pharmacokinetic comparison with the micronized form of the drug. Int. J. Pharm. 585, 119501. doi: 10.1016\/J.IJPHARM.2020.119501.","DOI":"10.1016\/j.ijpharm.2020.119501"},{"key":"10.1016\/j.ijpharm.2023.123720_b0225","doi-asserted-by":"crossref","unstructured":"Particle Size Reduction and Enlargement, 2019. Coulson Richardson\u2019s Chem. Eng. 205\u2013280. doi: 10.1016\/B978-0-08-101098-3.00006-8.","DOI":"10.1016\/B978-0-08-101098-3.00006-8"},{"key":"10.1016\/j.ijpharm.2023.123720_bib320","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2014.03.030","article-title":"Engineered nanocrystal technology: In-vivo fate, targeting and applications in drug delivery","volume":"183","author":"Pawar","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2023.123720_b0230","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.2042-7158.2010.01022.x","article-title":"Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods","volume":"62","author":"Peltonen","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2023.123720_bib321","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd1494","article-title":"Nanosuspensions in drug delivery","volume":"3","author":"Rabinow","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpharm.2023.123720_b0235","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1773-2247(12)50089-4","article-title":"Design and development of atorvastatin calcium buccoadhesive bilayered devices for oral drug delivery","volume":"22","author":"Ramani","year":"2012","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2023.123720_b0240","doi-asserted-by":"crossref","unstructured":"Real, J.P., Real, D.A., Lopez-Vidal, L., Barrientos, B.A., Bola\u00f1os, K., Tinti, M.G., Litterio, N.J., Kogan, M.J., Palma, S.D., 2023. 3D-printed gastroretentive tablets loaded with niclosamide nanocrystals by the melting solidification printing process (MESO-PP). Pharm. 15, 1387. doi: 10.3390\/PHARMACEUTICS15051387.","DOI":"10.3390\/pharmaceutics15051387"},{"key":"10.1016\/j.ijpharm.2023.123720_b0245","first-page":"23","article-title":"Manufacturing techniques for nanoparticles in drug delivery","author":"Real","year":"2022","journal-title":"Drug Deliv. Using Nanomater."},{"key":"10.1016\/j.ijpharm.2023.123720_b0250","article-title":"A quality by design approach for optimization of Lecithin\/Span\u00ae 80 based nanoemulsions loaded with hydrophobic drugs","author":"Real","year":"2020","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ijpharm.2023.123720_b0255","article-title":"Design and optimization of pH-sensitive Eudragit nanoparticles for improved oral delivery of triclabendazole","volume":"617","author":"Real","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2023.123720_b0260","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2017.07.752","article-title":"Optimizing cholesterol treatment in patients with muscle complaints","volume":"70","author":"Rosenson","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijpharm.2023.123720_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118891","article-title":"Improved solubility, dissolution, and oral bioavailability for atorvastatin-Pluronic\u00ae solid dispersions","volume":"574","author":"Shaker","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2023.123720_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120077","article-title":"Enhancement of atorvastatin oral bioavailability via encapsulation in polymeric nanoparticles","volume":"592","author":"Shaker","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2023.123720_b0275","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.matlet.2013.07.076","article-title":"A low temperature mechanochemical synthesis and characterization of amorphous Ni\u2013B ultrafine nanoparticles","volume":"109","author":"Shao","year":"2013","journal-title":"Mater. Lett."},{"key":"10.1016\/j.ijpharm.2023.123720_b0280","doi-asserted-by":"crossref","unstructured":"Sharma, M., Mehta, I., 2019. Surface stabilized atorvastatin nanocrystals with improved bioavailability, safety and antihyperlipidemic potential. Sci. Rep. 9, 1\u201311. doi: 10.1038\/s41598-019-52645-0.","DOI":"10.1038\/s41598-019-52645-0"},{"key":"10.1016\/j.ijpharm.2023.123720_b0285","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijpharm.2010.07.044","article-title":"Nanocrystals: Industrially feasible multifunctional formulation technology for poorly soluble actives","volume":"399","author":"Shegokar","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2023.123720_b0290","article-title":"The persistence and crystallization behavior of atorvastatin calcium amorphous dispersions in polyvinylpyrrolidone","volume":"72","author":"Tizaoui","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2023.123720_b0295","doi-asserted-by":"crossref","unstructured":"Tuomela, A., Hirvonen, J., Peltonen, L., 2016. Stabilizing agents for drug nanocrystals: effect on bioavailability. Pharm. 8, 16. doi: 10.3390\/PHARMACEUTICS8020016.","DOI":"10.3390\/pharmaceutics8020016"},{"key":"10.1016\/j.ijpharm.2023.123720_b0300","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11095-004-9004-4","article-title":"Predicting drug disposition via application of BCS: transport\/absorption\/elimination interplay and development of a biopharmaceutics drug disposition classification system","volume":"22","author":"Wu","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2023.123720_b0305","article-title":"Enhanced dissolution and oral bioavailbility of cinacalcet hydrochlorde nanocrystals with no food effect","volume":"30","author":"Xu","year":"2019","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ijpharm.2023.123720_b0310","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijpharm.2016.04.059","article-title":"Development of a solidified self-microemulsifying drug delivery system (S-SMEDDS) for atorvastatin calcium with improved dissolution and bioavailability","volume":"506","author":"Yeom","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2023.123720_b0315","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpharm.2009.02.015","article-title":"Micronization of atorvastatin calcium by antisolvent precipitation process","volume":"374","author":"Zhang","year":"2009","journal-title":"Int. J. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517323011420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517323011420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:48:21Z","timestamp":1736383701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517323011420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":69,"alternative-id":["S0378517323011420"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123720","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significant progress in improving Atorvastatin dissolution rate: Physicochemical characterization and stability assessment of self-dispersible Atorvastatin\/Tween 80\u00ae nanocrystals formulated through wet milling and freeze-drying","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123720"}}